Vimarsana
Biggest News Aggregation in the World

Arvind Utchanah News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arvind Utchanah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arvind Utchanah Today - Breaking & Trending Today

Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call - Vimarsana News

Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call

MONTREAL, May 02, 2024 -- Knight Therapeutics Inc. , a leading pan-American specialty pharmaceutical company, will release its first quarter 2024 financial results on Thursday, May 9, 2024 prior...

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Vimarsana News

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 09, 2024 -- Knight Therapeutics Inc. , a leading pan-American specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is...

Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity -March 28, 2024 at 11:04 am EDT - Vimarsana News

Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity -March 28, 2024 at 11:04 am EDT

MONTREAL, March 28, 2024 -- Knight Therapeutics Inc. is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list....

Knight Therapeutics Inc. Celebrates its First Decade of Success - Vimarsana News

Knight Therapeutics Inc. Celebrates its First Decade of Success

MONTREAL, Feb. 28, 2024 -- Knight Therapeutics Inc. , a pan-American specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of...

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil - Vimarsana News

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

MONTREAL, Feb. 21, 2024 -- Knight Therapeutics Inc., a pan-American specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a...